The Impact of Permanent Pacemaker Implantation After TAVI on Mortality and Quality of Life: A POPular TAVI Substudy

IF 2.1 3区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Catheterization and Cardiovascular Interventions Pub Date : 2025-01-29 DOI:10.1002/ccd.31431

P. J. A. van Nuland, J. Halim, D. J. van Ginkel, D. C. Overduin, J. Brouwer, V. J. Nijenhuis, A. W. J. van't Hof, P. A. L. Tonino, J. M. ten Berg, P. A. Vriesendorp

{"title":"The Impact of Permanent Pacemaker Implantation After TAVI on Mortality and Quality of Life: A POPular TAVI Substudy","authors":"P. J. A. van Nuland, J. Halim, D. J. van Ginkel, D. C. Overduin, J. Brouwer, V. J. Nijenhuis, A. W. J. van't Hof, P. A. L. Tonino, J. M. ten Berg, P. A. Vriesendorp","doi":"10.1002/ccd.31431","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Conduction disturbances are common after transcatheter aortic valve implantation (TAVI) and frequently require permanent pacemaker implantation (PPI). Data regarding its impact on mortality and morbidity are conflicting. This study aims to assess the impact of PPI before or within 30 days after TAVI on mortality and health-related Quality of Life (QoL) during the first year after TAVI.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In this POPular TAVI substudy, 978 patients were included and categorized into three groups: Neither PPI before or within 30 days after TAVI (no PPI, <i>n</i> = 779), PPI before TAVI (PPI pre-TAVI, <i>n</i> = 102), PPI within 30 days after TAVI (PPI post-TAVI, n = 97). All-cause death and cardiac death were evaluated at 1 year. QoL was assessed using the SF-12 and EQ-5D-5L questionnaires at baseline and 3, 6, and 12 months.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>At 1-year, all-cause death was seen in 6.9% (PPI pre-TAVI, <i>p</i> = 0.53) and 10.3% (PPI post-TAVI, <i>p</i> = 0.66) of the patients compared to 8.7% of the patients (no PPI). Cardiac death was observed in 4.9% (PPI pre-TAVI, <i>p</i> = 0.58) and 6.2% (PPI post-TAVI, <i>p</i> = 0.94) of the patients compared to 6.2% of patients (no PPI). Regarding QoL, the PPI pre-TAVI group showed lower PCS-12 over time compared to the no PPI group (<i>p</i> = 0.04), while MCS-12, EQ-5D Index and EQ-5D VAS scores were equal. No significant differences in QoL were seen between the PPI post-TAVI group and the no PPI group.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>PPI before or within 30 days after TAVI was not associated with increased mortality within 1 year. PPI pre-TAVI was associated with lower physical QoL.</p>\n </section>\n </div>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"105 5","pages":"1098-1107"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Catheterization and Cardiovascular Interventions","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ccd.31431","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Conduction disturbances are common after transcatheter aortic valve implantation (TAVI) and frequently require permanent pacemaker implantation (PPI). Data regarding its impact on mortality and morbidity are conflicting. This study aims to assess the impact of PPI before or within 30 days after TAVI on mortality and health-related Quality of Life (QoL) during the first year after TAVI.

Methods

In this POPular TAVI substudy, 978 patients were included and categorized into three groups: Neither PPI before or within 30 days after TAVI (no PPI, n = 779), PPI before TAVI (PPI pre-TAVI, n = 102), PPI within 30 days after TAVI (PPI post-TAVI, n = 97). All-cause death and cardiac death were evaluated at 1 year. QoL was assessed using the SF-12 and EQ-5D-5L questionnaires at baseline and 3, 6, and 12 months.

Results

At 1-year, all-cause death was seen in 6.9% (PPI pre-TAVI, p = 0.53) and 10.3% (PPI post-TAVI, p = 0.66) of the patients compared to 8.7% of the patients (no PPI). Cardiac death was observed in 4.9% (PPI pre-TAVI, p = 0.58) and 6.2% (PPI post-TAVI, p = 0.94) of the patients compared to 6.2% of patients (no PPI). Regarding QoL, the PPI pre-TAVI group showed lower PCS-12 over time compared to the no PPI group (p = 0.04), while MCS-12, EQ-5D Index and EQ-5D VAS scores were equal. No significant differences in QoL were seen between the PPI post-TAVI group and the no PPI group.

Conclusion

PPI before or within 30 days after TAVI was not associated with increased mortality within 1 year. PPI pre-TAVI was associated with lower physical QoL.

查看原文本刊更多论文

TAVI术后永久起搏器植入对死亡率和生活质量的影响：一项流行的TAVI亚研究。

背景：经导管主动脉瓣植入术（TAVI）后传导障碍很常见，通常需要永久性起搏器植入术（PPI）。关于其对死亡率和发病率影响的数据相互矛盾。本研究旨在评估TAVI术前或术后30天内PPI对TAVI术后一年内死亡率和健康相关生活质量（QoL）的影响。方法：在这项POPular TAVI亚研究中，纳入978例患者，分为三组：TAVI前或后30天内未PPI (n = 779)， TAVI前未PPI (n = 102)， TAVI后30天内PPI （n = 97）。1年时评估全因死亡和心源性死亡。在基线和3、6和12个月时使用SF-12和EQ-5D-5L问卷评估生活质量。结果：1年时，全因死亡率分别为6.9% （tavi前PPI， p = 0.53）和10.3% (tavi后PPI， p = 0.66)，而非PPI组的全因死亡率为8.7%。4.9% （tavi前PPI， p = 0.58）和6.2% （tavi后PPI， p = 0.94）的患者发生心源性死亡，而未发生PPI的患者为6.2%。在生活质量方面，tavi前PPI组的PCS-12随时间的推移低于未PPI组（p = 0.04），而MCS-12、EQ-5D指数和EQ-5D VAS评分相等。tavi后PPI组与未PPI组的生活质量无显著差异。结论：TAVI术前或术后30天内PPI与1年内死亡率升高无关。tavi前PPI与较低的物理生活质量相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Catheterization and Cardiovascular Interventions 医学-心血管系统

CiteScore

5.40

自引率

8.70%

发文量

419

审稿时长

2 months

期刊介绍： Catheterization and Cardiovascular Interventions is an international journal covering the broad field of cardiovascular diseases. Subject material includes basic and clinical information that is derived from or related to invasive and interventional coronary or peripheral vascular techniques. The journal focuses on material that will be of immediate practical value to physicians providing patient care in the clinical laboratory setting. To accomplish this, the journal publishes Preliminary Reports and Work In Progress articles that complement the traditional Original Studies, Case Reports, and Comprehensive Reviews. Perspective and insight concerning controversial subjects and evolving technologies are provided regularly through Editorial Commentaries furnished by members of the Editorial Board and other experts. Articles are subject to double-blind peer review and complete editorial evaluation prior to any decision regarding acceptability.